ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.599,57
-0,46%
S&P 500
5.222,68
0,16%
US Dollar vs BRL
5,1557
0,26%
Bitcoin
60.615,85
-3,86%
Brent Oil
82,665
-1,53%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Precigen Inc (PGEN)

  7. Precigen Inc (PGEN) Notícias

PGEN

Precigen (PGEN)

Precigen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PGEN
DataHoraFonteTítuloCódigoCompanhia
08/05/202417:05PR Newswire (US)Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
24/04/202411:20PR Newswire (US)Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
24/04/202410:00PR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:PGENPrecigen Inc
28/03/202417:05PR Newswire (US)Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11thNASDAQ:PGENPrecigen Inc
19/03/202417:05PR Newswire (US)Precigen Reports Full Year 2023 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
19/03/202408:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:PGENPrecigen Inc
12/03/202417:05PR Newswire (US)Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:PGENPrecigen Inc
05/03/202418:05PR Newswire (US)Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19thNASDAQ:PGENPrecigen Inc
27/02/202415:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PGENPrecigen Inc
14/02/202418:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PGENPrecigen Inc
08/02/202418:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
06/02/202418:05PR Newswire (US)Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:PGENPrecigen Inc
18/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PGENPrecigen Inc
16/01/202410:05PR Newswire (US)Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European CommissionNASDAQ:PGENPrecigen Inc
08/01/202410:30PR Newswire (US)Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
29/12/202319:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PGENPrecigen Inc
18/12/202318:05PR Newswire (US)Precigen to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
29/11/202318:05PR Newswire (US)Precigen to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:PGENPrecigen Inc
09/11/202319:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
09/11/202318:55PR Newswire (US)Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical ProgramsNASDAQ:PGENPrecigen Inc
07/11/202318:05PR Newswire (US)Precigen to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PGENPrecigen Inc
19/09/202317:05PR Newswire (US)Precigen to Participate in Upcoming Leading Investor and Industry ConferencesNASDAQ:PGENPrecigen Inc
25/08/202320:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
09/08/202309:00PR Newswire (US)Precigen Reports Second Quarter and First Half 2023 Financial Results and Provides Update on Portfolio Prioritization and Capital Allocation Strategies to Extend Projected Cash Runway into 2025NASDAQ:PGENPrecigen Inc
09/08/202308:05PR Newswire (US)Precigen Announces FDA Confirmation that the Ongoing Phase 1/2 Study of PRGN-2012 AdenoVerse Immunotherapy Will Serve as the Pivotal Study to Support Accelerated ApprovalNASDAQ:PGENPrecigen Inc
03/08/202317:05PR Newswire (US)Precigen to Announce Second Quarter and First Half 2023 Financial Results on August 9thNASDAQ:PGENPrecigen Inc
06/07/202318:09Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PGENPrecigen Inc
20/06/202309:21Dow Jones NewsPrecigen Gets FDA Breakthrough Therapy Designation for AdenoVerseNASDAQ:PGENPrecigen Inc
20/06/202308:30PR Newswire (US)Precigen Receives Breakthrough Therapy Designation for PRGN-2012 AdenoVerse™ Immunotherapy for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:PGENPrecigen Inc
09/06/202317:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PGENPrecigen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PGEN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
VVEO3
CM Hospitalar ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
PRIO3
PETRORIO ON
BOV
LUPA3
LUPATECH ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
UNIP6
UNIPAR PNB
BOV
HAGA3
HAGA ON
BOV
TELB4
TELEBRAS PN
BOV
SGPS3
SPRINGS ON
BOV
PDTC3
Padtec ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados